TrialClinical and vaccine immunology : CVI2013

Combined administration of MF59-adjuvanted A/H5N1 prepandemic and seasonal influenza vaccines: long-term antibody persistence and robust booster responses 1 year after a one-dose priming schedule.

Pio Lopez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.